PMC8276930_01
Ultrasound scan on 31 October 2019
2639_Fig1.jpg
PMC8276930_01_2639_Fig1.jpg
f1-2639-1-23195-1-10-20210616
The patient then underwent a liver ultrasound (Fig. 1) which was negative for metastasis.
CT scans on 11 November 2019 (A), 17 December 2019 (B) and 23 December 2019 (C)
2639_Fig2.jpg
PMC8276930_01_2639_Fig2.jpg
f2-2639-1-23195-1-10-20210616
In November 2019, the patient underwent an abdominal CT scan (Fig. 2A) which showed a slightly enlarged liver without focal lesions. On 17 December, she underwent an abdominal CT scan (Fig. 2B) which showed progressive disease but no liver involvement.
Ultrasound scan on 27 November 2019
2639_Fig3.jpg
PMC8276930_01_2639_Fig3.jpg
f3-2639-1-23195-1-10-20210616
At the end of November, the patient started mycophenolate 100 mg twice daily and underwent liver ultrasound plus-guided biopsy (Fig. 3).
Liver enzyme trends.. ALT, alanine transaminase (U/l); BIL, bilirubin (mg/dl); GGT, gamma-glutamyl transpeptidase (U/l)
2639_Fig4.jpg
PMC8276930_01_2639_Fig4.jpg
f4-2639-1-23195-1-10-20210616
Liver enzyme trends are shown in Fig. 4.